We are live on ! Find out more
SBFMW

Sunshine Biopharma Inc Warrant
SBFMW

4 hedge funds and large institutions have $13.3K invested in Sunshine Biopharma Inc Warrant in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 44 (0)

0.02% less ownership

Funds ownership: 0.27%0.25% (-0.02%)

14% less capital invested

Capital invested by funds: $15.4K → $13.3K (-$2.1K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$22
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$12.9K -$930 -4,226 -6%
CS
2
Clear Street
New York
$415 -$22 -100 -5%
Bank of America
3
Bank of America
North Carolina
$30 +$22 +100 +100%
UBS Group
4
UBS Group
Switzerland
$15 -$124 -562 -85%

SBFMW Hedge Fund Activity: Q4 2023 in Review

4 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q4 2023, worth a combined $13.3K — down 14% from $15.4K a quarter earlier.

Fund positioning in SBFMW was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Bank of America, adding an estimated $22. The largest seller was Citadel Advisors, cutting an estimated $930.

  • 4 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $13.3K of Sunshine Biopharma Inc Warrant stock for Q4 2023, down 14% quarter-over-quarter.
  • 0 funds opened new Sunshine Biopharma Inc Warrant positions in Q4 2023 and 0 closed out.
  • The largest Sunshine Biopharma Inc Warrant buyer in Q4 2023 was Bank of America, an estimated $22 added.
  • The largest Sunshine Biopharma Inc Warrant seller in Q4 2023 was Citadel Advisors, an estimated $930 sold.

Based on aggregated 13F filings for Q4 2023.